NPS Pharma (NPSP) Reports Smaller-Than-Expected Loss
Tweet Send to a Friend
NPS Pharm (NASDAQ: NPSP) reports Q4 EPS of $0.04, 9 cents better than the analyst estimate of ($0.13). Revenue ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
